Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-078801
Filing Date
2022-07-11
Accepted
2022-07-11 16:09:04
Documents
1
Period of Report
2022-07-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220760-9_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220760-9_4seq1.xml 4 15010
  Complete submission text file 0001104659-22-078801.txt   16434
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Ronsheim Matthew (Reporting) CIK: 0001824386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 221077040